2.0
26. März 2023
Aktueller Mitarbeiter, mehr als 1 Jahr
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great products and interesting work. Cutting edge technology
Kontras
Very poor pay. Almost 10 years behind. Convoluted comp plan. High turnover within the sales and clinical team. The ones who are left behind have to work 4x as hard to make sure customers are supported.